Heritability of clotting factors and the revival of the prothrombotic state

Lancet

Volumn 359, Issue 9307, 2002, Pages 638-639

  Rosendaal, F R ^a   Bovill, E G ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; D DIMER; ENZYME INHIBITOR; FATTY ACID BINDING PROTEIN; FIBRINOGEN; FIBRINOPEPTIDE A; PLASMINOGEN ACTIVATOR INHIBITOR 3; PROCOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TRYPSIN INHIBITOR;

BLOOD VESSEL WALL; CARDIOVASCULAR RISK; ENDOTHELIUM INJURY; GENE MUTATION; GENETIC DISORDER; HEART INFARCTION; HEMOSTASIS; HERITABILITY; HUMAN; HYPERCOAGULABILITY; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFECT; STROKE; THROMBOSIS; VEIN THROMBOSIS;

EID: 0037160755     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07779-6     Document Type: Note

References (10)

1. The haemostatic balance
2. Risk factors for venous thrombotic disease
3. Familial clustering of factor VIII and von Willebrand factor levels
4. The genetics of haemostasis: A twin study
5. Genetic determinants of hemostasis phenotypes in Spanish families
6. Heritability of clotting factors, coagulation inhibitors and activation peptides
7. The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation
8. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin-antithrombin complex
9. D-Dimer as a risk factor for venous thrombosis: The Leiden thrombophilia study